Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and may not all relate to the study; the page revision note has been updated to Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page no longer displays the general government funding operating-status notice. Core study details (design, endpoints, and locations) remain unchanged.SummaryDifference0.2%

- Check26 days agoChange DetectedAdded Tainan, Taiwan as a study site and removed Tainan City, Taiwan from the location list.SummaryDifference0.0%

- Check40 days agoChange DetectedNo core study content changed: the title, design, arms, primary and secondary outcomes, eligibility criteria, and locations remain the same; observed differences are limited to minor formatting and layout adjustments of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedUpdate: page now includes a government-operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedUpdate includes a new version tag (v3.1.0) and removal of several risk-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2).SummaryDifference0.2%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.